Anti-infectives · CNS drugs · Pharmaceuticals
Shionogi & Co.
A Japanese pharmaceutical company developing treatments for infectious and central-nervous-system diseases. Nikkei 225 constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
Business categories Pharmaceuticals & Biotechnology · Biopharma & Life Sciences · primary
4507.T Updated Jul 11, 2026 4 AI consumers· 2 recurring
Annual return · 2026-09-04'21+15%'22-2.2%'23+17.8%'24-1%'25+42.4%YTD-7.3%
Money in ▸·
Shionogi & Co.~¥440B
▸ Money out·
Financials & Segments
- Total revenue · ~¥440B (FY2024)
- Segments · Pharmaceuticals
Revenue from
No refined links yet.
Pays to
No refined links yet.